Joel Singer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joel Singer has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan Peter Little
School of Health and Exercise Sciences University of British Columbia Okanagan Kelowna British Columbia Canada
7 shared publications - Kaja Falkenhain
School of Health and Exercise Sciences University of British Columbia Okanagan Kelowna British Columbia Canada
7 shared publications - Terry Lee
Providence Health Care Research Institute, University of British Columbia
7 shared publications - Dylan A Lowe
Eureka Research Platform San Francisco, CA United States
4 shared publications - Ethan J. Weiss
UCSF
4 shared publications - Kenneth Michael Madden
Gerontology and Diabetes Research Laboratory, Division of Geriatric Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
4 shared publications
Latest Publications
- Open Access
- 25 July 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (10) , 9294-9303
Exercise Snacks Are Feasible to Perform in the Real World and Improve Physical Capacity for Adults Living With Non‐Insulin Treated Type 2 Diabetes: A Randomised Trial
Aims: To investigate the feasibility and preliminary efficacy of a 12‐week remotely‐delivered exercise snacks (ES) intervention in adults with type 2 diabetes. Material and Methods: Insufficiently active adults with type 2 diabetes ( N = 69; 46 females; mean age ± SD: 58 ± 11 years) were randomised to an ES or mobility/stretching comparator group (CON), which involved 4 × 1‐min bouts of either vigorous or low intensity exercise, respectively, on ≥ 5 days/week. The primary outcome was feasibility based on adherence. Secondary outcomes included exercise enjoyment (1–7 scale), rating of perceived exertion (RPE; 0–10 scale), heart rate (HR), haemoglobin A 1c (HbA 1c ), blood biomarkers of cardiometabolic health, 30‐s sit‐to‐stand capacity, grip strength, estimated maximal oxygen uptake, and anthropometrics. Results: Weekly adherence (estimated marginal mean [95% confidence interval]: 18 bouts [16–21] for both groups; p = 0.99) and total enjoyment (ES: 4.5 [4.1–4.8] vs. CON: 4.3 [4.0–4.7]; p = 0.64) were high and not different between groups. Despite higher RPE (5.7 [5.4–6.1]) and peak HR (73 [70–77] % of age‐predicted HR maximum) in ES versus CON (2.0 [1.7–2.4] and 61 [58–64] % of age‐predicted HR maximum, respectively) (all p < 0.001), there were no between‐group differences in the change in any secondary outcome (all p > 0.05) except for greater sit‐to‐stand capacity in ES after training (between‐group effect estimate [95% confidence interval]: 1.9 repetitions [0.3–3.4]; p = 0.02). Conclusions: Exercise snacks were feasible to perform in the real world and improved sit‐to‐stand capacity to a greater extent than CON in adults living with type 2 diabetes. Trial Registration: ClinicalTrials.gov identifier: NCT06407245
- 25 July 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (10) , 9294-9303
Open AccessExercise Snacks Are Feasible to Perform in the Real World and Improve Physical Capacity for Adults Living With Non‐Insulin Treated Type 2 Diabetes: A Randomised Trial
Aims: To investigate the feasibility and preliminary efficacy of a 12‐week remotely‐delivered exercise snacks (ES) intervention in adults with type 2 diabetes. Material and Methods: Insufficiently active adults with type 2 diabetes ( N = 69; 46 females; mean age ± SD: 58 ± 11 years) were randomised to an ES or mobility/stretching comparator group (CON), which involved 4 × 1‐min bouts of either vigorous or low intensity exercise, respectively, on ≥ 5 days/week. The primary outcome was feasibility based on adherence. Secondary outcomes included exercise enjoyment (1–7 scale), rating of perceived exertion (RPE; 0–10 scale), heart rate (HR), haemoglobin A 1c (HbA 1c ), blood biomarkers of cardiometabolic health, 30‐s sit‐to‐stand capacity, grip strength, estimated maximal oxygen uptake, and anthropometrics. Results: Weekly adherence (estimated marginal mean [95% confidence interval]: 18 bouts [16–21] for both groups; p = 0.99) and total enjoyment (ES: 4.5 [4.1–4.8] vs. CON: 4.3 [4.0–4.7]; p = 0.64) were high and not different between groups. Despite higher RPE (5.7 [5.4–6.1]) and peak HR (73 [70–77] % of age‐predicted HR maximum) in ES versus CON (2.0 [1.7–2.4] and 61 [58–64] % of age‐predicted HR maximum, respectively) (all p < 0.001), there were no between‐group differences in the change in any secondary outcome (all p > 0.05) except for greater sit‐to‐stand capacity in ES after training (between‐group effect estimate [95% confidence interval]: 1.9 repetitions [0.3–3.4]; p = 0.02). Conclusions: Exercise snacks were feasible to perform in the real world and improved sit‐to‐stand capacity to a greater extent than CON in adults living with type 2 diabetes. Trial Registration: ClinicalTrials.gov identifier: NCT06407245
- Open Access
- 24 April 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (8) , 2200-2211
Exercise snacks performed in real-world settings reduce postprandial hyperglycaemia and glycaemic variability in individuals living with type 2 diabetes: a randomised crossover study
Aims/hypothesis Using a randomised, crossover design, we investigated whether exercise snacks could improve indices of glucose regulation assessed by continuous glucose monitoring, compared with an equivalent no-exercise control period in people living with non-insulin-treated type 2 diabetes. Methods Previously inactive participants with well-controlled type 2 diabetes (n=31; 21 female participants, ten male participants; approximately 58 years old, BMI approximately 31 kg/m2, HbA1c approximately 48 mmol/mol [6.6%]) completed two experimental conditions in a randomised, counterbalanced order in the real world under a standardised diet. During the exercise snacks condition (ES), participants completed four 1 min bouts of vigorous bodyweight exercise on two consecutive days, guided by instructional videos sent via email. The control condition (CON) involved two consecutive days of no exercise. Participants wore a continuous glucose monitor and a Fitbit watch to record glycaemic responses and heart rate, respectively. The primary outcome was mean glucose during each 48 h condition. Secondary outcomes included 2 h postprandial glucose responses after standardised meals and markers of glycaemic variability. Results The difference in mean glucose between ES and CON did not reach statistical significance (between-condition difference −0.2 mmol/l; 95% CI −0.4, 0.0; p=0.07). However, small but statistically significant improvements in standard deviation (−0.1 mmol/l; 95% CI −0.2, −0.1; pp=0.007), mean amplitude of glycaemic excursions (−0.3 mmol/l; 95% CI −0.5, 0.0; p=0.04) and time in tight range (3%; 95% CI 0, 6; p=0.04) were seen under the ES condition compared with CON. The 2 h postprandial glucose average, peak, area under the curve and incremental area under the curve were also significantly lower after breakfast and dinner during the ES condition compared with CON (all pTrial registration ClinicalTrials.gov NCT06382246 Graphical Abstract The alternative text for this image may have been generated using AI.
- 24 April 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (8) , 2200-2211
Open AccessExercise snacks performed in real-world settings reduce postprandial hyperglycaemia and glycaemic variability in individuals living with type 2 diabetes: a randomised crossover study
Aims/hypothesis Using a randomised, crossover design, we investigated whether exercise snacks could improve indices of glucose regulation assessed by continuous glucose monitoring, compared with an equivalent no-exercise control period in people living with non-insulin-treated type 2 diabetes. Methods Previously inactive participants with well-controlled type 2 diabetes (n=31; 21 female participants, ten male participants; approximately 58 years old, BMI approximately 31 kg/m2, HbA1c approximately 48 mmol/mol [6.6%]) completed two experimental conditions in a randomised, counterbalanced order in the real world under a standardised diet. During the exercise snacks condition (ES), participants completed four 1 min bouts of vigorous bodyweight exercise on two consecutive days, guided by instructional videos sent via email. The control condition (CON) involved two consecutive days of no exercise. Participants wore a continuous glucose monitor and a Fitbit watch to record glycaemic responses and heart rate, respectively. The primary outcome was mean glucose during each 48 h condition. Secondary outcomes included 2 h postprandial glucose responses after standardised meals and markers of glycaemic variability. Results The difference in mean glucose between ES and CON did not reach statistical significance (between-condition difference −0.2 mmol/l; 95% CI −0.4, 0.0; p=0.07). However, small but statistically significant improvements in standard deviation (−0.1 mmol/l; 95% CI −0.2, −0.1; pp=0.007), mean amplitude of glycaemic excursions (−0.3 mmol/l; 95% CI −0.5, 0.0; p=0.04) and time in tight range (3%; 95% CI 0, 6; p=0.04) were seen under the ES condition compared with CON. The 2 h postprandial glucose average, peak, area under the curve and incremental area under the curve were also significantly lower after breakfast and dinner during the ES condition compared with CON (all pTrial registration ClinicalTrials.gov NCT06382246 Graphical Abstract The alternative text for this image may have been generated using AI.
- Open Access
Exercise snacks are feasible to perform in the real world and improve physical capacity for adults living with non-insulin treated type 2 diabetes: a randomized trial
Aims/hypothesis: To investigate the feasibility and preliminary efficacy of a 12-week remotely-delivered exercise snacks (ES) intervention in adults with type 2 diabetes. Methods: Insufficiently active adults with type 2 diabetes (N=69; 46 females; mean age ± SD: 58±11 years) were randomized to an ES or mobility/stretching comparator group (CON), which involved 4 × 1-min bouts of either vigorous or low intensity exercise, respectively, on ≥5 days/week. The primary outcome was feasibility based on adherence. Secondary outcomes included exercise enjoyment (1-7 scale), rating of perceived exertion (RPE; 0-10 scale), heart rate (HR), hemoglobin A 1c (HbA 1c ), blood biomarkers of cardiometabolic health, 30-second sit-to-stand capacity, grip strength, estimated maximal oxygen uptake, and anthropometrics. Results: Weekly adherence (estimated marginal mean [95% confidence interval]: 18 bouts [16 to 21] for both groups; P=0.99) and total enjoyment (ES: 4.5 [4.1 to 4.8] vs CON: 4.3 [4.0 to 4.7]; P=0.64) were high and not different between groups. Despite higher RPE (5.7 [5.4 to 6.1]) and peak HR (73 [70 to 77] % of age-predicted HR maximum) in ES vs CON (2.0 [1.7 to 2.4] and 61 [58 to 64] % of age-predicted HR maximum, respectively) (all P0.05) except for greater sit-to-stand capacity in ES after training (between-group effect estimate [95% confidence interval]: 1.9 repetitions [0.3 to 3.4]; P=0.02). Conclusions/interpretation: Exercise snacks were feasible to perform in the real-world and improved physical capacity to a greater extent than CON in adults living with type 2 diabetes. Trial registration: ClinicalTrials.gov ID: NCT06407245 Research in Context: What is already known about this subject?: Exercise snacks (≤1-min bouts of vigorous exercise spaced out across the day) are a time-efficient and practical approach to promote vigorous exercise and break up sedentary time. Real-world exercise snack interventions appear feasible for middle-aged and older adults. What is the key question?: Are 12 weeks of exercise snacks performed in the real-world feasible for insufficiently active adults living with non-insulin treated type 2 diabetes? What are the new findings?: Exercise snacks are feasible for those living with type 2 diabetes to perform unsupervised in the real-world based on high adherence, enjoyment, and participant retention rates. Exercise snacks improved 30-second sit-to-stand capacity and reduced waist circumference suggesting enhancements in physical capacity and body composition. How might this impact on clinical practice in the foreseeable future?: Exercise snacks could be utilized to help individuals living with type 2 diabetes build a routine or habit of incorporating small amounts of physical activity into their daily lives. The improved physical capacity observed in the current study could contribute to lower fall risk and greater lower body strength in those with type 2 diabetes as they age.
Open AccessExercise snacks are feasible to perform in the real world and improve physical capacity for adults living with non-insulin treated type 2 diabetes: a randomized trial
Aims/hypothesis: To investigate the feasibility and preliminary efficacy of a 12-week remotely-delivered exercise snacks (ES) intervention in adults with type 2 diabetes. Methods: Insufficiently active adults with type 2 diabetes (N=69; 46 females; mean age ± SD: 58±11 years) were randomized to an ES or mobility/stretching comparator group (CON), which involved 4 × 1-min bouts of either vigorous or low intensity exercise, respectively, on ≥5 days/week. The primary outcome was feasibility based on adherence. Secondary outcomes included exercise enjoyment (1-7 scale), rating of perceived exertion (RPE; 0-10 scale), heart rate (HR), hemoglobin A 1c (HbA 1c ), blood biomarkers of cardiometabolic health, 30-second sit-to-stand capacity, grip strength, estimated maximal oxygen uptake, and anthropometrics. Results: Weekly adherence (estimated marginal mean [95% confidence interval]: 18 bouts [16 to 21] for both groups; P=0.99) and total enjoyment (ES: 4.5 [4.1 to 4.8] vs CON: 4.3 [4.0 to 4.7]; P=0.64) were high and not different between groups. Despite higher RPE (5.7 [5.4 to 6.1]) and peak HR (73 [70 to 77] % of age-predicted HR maximum) in ES vs CON (2.0 [1.7 to 2.4] and 61 [58 to 64] % of age-predicted HR maximum, respectively) (all P0.05) except for greater sit-to-stand capacity in ES after training (between-group effect estimate [95% confidence interval]: 1.9 repetitions [0.3 to 3.4]; P=0.02). Conclusions/interpretation: Exercise snacks were feasible to perform in the real-world and improved physical capacity to a greater extent than CON in adults living with type 2 diabetes. Trial registration: ClinicalTrials.gov ID: NCT06407245 Research in Context: What is already known about this subject?: Exercise snacks (≤1-min bouts of vigorous exercise spaced out across the day) are a time-efficient and practical approach to promote vigorous exercise and break up sedentary time. Real-world exercise snack interventions appear feasible for middle-aged and older adults. What is the key question?: Are 12 weeks of exercise snacks performed in the real-world feasible for insufficiently active adults living with non-insulin treated type 2 diabetes? What are the new findings?: Exercise snacks are feasible for those living with type 2 diabetes to perform unsupervised in the real-world based on high adherence, enjoyment, and participant retention rates. Exercise snacks improved 30-second sit-to-stand capacity and reduced waist circumference suggesting enhancements in physical capacity and body composition. How might this impact on clinical practice in the foreseeable future?: Exercise snacks could be utilized to help individuals living with type 2 diabetes build a routine or habit of incorporating small amounts of physical activity into their daily lives. The improved physical capacity observed in the current study could contribute to lower fall risk and greater lower body strength in those with type 2 diabetes as they age.
- Open Access
Smart Discharges improves post-discharge mortality among children with suspected sepsis in Uganda: A prospective before-after study
Introduction: Post-discharge mortality among children following an acute illness in low-resource settings is high and demands urgent attention. We aimed to assess the impact of Smart Discharges, a mortality prevention risk-differentiated approach to peri-discharge care among children under five years admitted with suspected sepsis. Methods: We conducted a before-after two-phase study with staggered implementation at six hospitals in Uganda. During a baseline period (Phase-1), clinical prediction algorithms for post-discharge mortality were developed based on clinical and socio-demographic data collected at hospital admission. Outcomes, primarily mortality within six months of discharge, were compared against an interventional period (Phase-2). In the Smart Discharges intervention each family was given soap, a mosquito net, their risk category (low/medium/high/very high), counselling, and educational materials regardless of risk stratification, after which the intensity of recommended follow-up care was determined by age (0-6, 6-60 months) and predicted post-discharge mortality risk. Results: Overall, 13,051 children were enrolled: Phase-1, n=6,955; Phase-2, n=6,096. Characteristics were similar between groups, including mean predicted post-discharge mortality risk (6.3% Phase-1 vs. 5.9% Phase-2). With Smart Discharges, 2,331/3,891 (59.9%) medium/high/very high-risk families attending all their scheduled visits. The observed post-discharge mortality rate was 439 (6.3%) in Phase-1 vs. 296 (4.9%) in Phase-2; adjusted hazard ratio 0.77 (95%CI 0.67 to 0.90) favouring the intervention. In Phase-1, 1,313 (18.9%) children were re-admitted to hospital vs. 1,024 (16.8%) in Phase-2. Conclusion: A simple approach of risk assessment paired with education and engagement through scheduled follow-up after discharge is an appropriate strategy to improve child survival in low-resource settings.
Open AccessSmart Discharges improves post-discharge mortality among children with suspected sepsis in Uganda: A prospective before-after study
Introduction: Post-discharge mortality among children following an acute illness in low-resource settings is high and demands urgent attention. We aimed to assess the impact of Smart Discharges, a mortality prevention risk-differentiated approach to peri-discharge care among children under five years admitted with suspected sepsis. Methods: We conducted a before-after two-phase study with staggered implementation at six hospitals in Uganda. During a baseline period (Phase-1), clinical prediction algorithms for post-discharge mortality were developed based on clinical and socio-demographic data collected at hospital admission. Outcomes, primarily mortality within six months of discharge, were compared against an interventional period (Phase-2). In the Smart Discharges intervention each family was given soap, a mosquito net, their risk category (low/medium/high/very high), counselling, and educational materials regardless of risk stratification, after which the intensity of recommended follow-up care was determined by age (0-6, 6-60 months) and predicted post-discharge mortality risk. Results: Overall, 13,051 children were enrolled: Phase-1, n=6,955; Phase-2, n=6,096. Characteristics were similar between groups, including mean predicted post-discharge mortality risk (6.3% Phase-1 vs. 5.9% Phase-2). With Smart Discharges, 2,331/3,891 (59.9%) medium/high/very high-risk families attending all their scheduled visits. The observed post-discharge mortality rate was 439 (6.3%) in Phase-1 vs. 296 (4.9%) in Phase-2; adjusted hazard ratio 0.77 (95%CI 0.67 to 0.90) favouring the intervention. In Phase-1, 1,313 (18.9%) children were re-admitted to hospital vs. 1,024 (16.8%) in Phase-2. Conclusion: A simple approach of risk assessment paired with education and engagement through scheduled follow-up after discharge is an appropriate strategy to improve child survival in low-resource settings.
- Open Access
- 20 February 2023
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 162 (2) , 614-622
Type and timing of antiretroviral therapy during pregnancy: Impact on risk of preterm delivery and small‐for‐gestational age births in Canada, a retrospective cohort study
Objective: To evaluate the impact of type and timing of antiretroviral therapy (ART) on the risk of preterm delivery (PTD) and small‐for‐gestational age (SGA) birth among pregnant women and people living with HIV in Canada.Methods: Data for this retrospective cohort study were analyzed from the Canadian Perinatal HIV Surveillance Program from 1990 to 2020. The association between ART and risk of PTD (P = 0.005).Conclusion: INSTI‐based ART regimens were associated with lower risk of PTD compared with other regimens, and ART initiation before conception was associated with a lower risk of SGA birth. These findings, with overall safety data, should be considered when providing pregnancy counseling to people living with HIV.
- 20 February 2023
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 162 (2) , 614-622
Open AccessType and timing of antiretroviral therapy during pregnancy: Impact on risk of preterm delivery and small‐for‐gestational age births in Canada, a retrospective cohort study
Objective: To evaluate the impact of type and timing of antiretroviral therapy (ART) on the risk of preterm delivery (PTD) and small‐for‐gestational age (SGA) birth among pregnant women and people living with HIV in Canada.Methods: Data for this retrospective cohort study were analyzed from the Canadian Perinatal HIV Surveillance Program from 1990 to 2020. The association between ART and risk of PTD (P = 0.005).Conclusion: INSTI‐based ART regimens were associated with lower risk of PTD compared with other regimens, and ART initiation before conception was associated with a lower risk of SGA birth. These findings, with overall safety data, should be considered when providing pregnancy counseling to people living with HIV.
- 7 November 2022
- Published by Springer Nature in AIDS and Behavior
- Vol. 27 (4) , 1350-1363
Disentangling Medicinal and Recreational cannabis Use Among People Living with HIV: An Ecological Momentary Assessment Study
This study examined the feasibility of using ecological momentary assessment (EMA) to disentangle medicinal cannabis use (MCU) from recreational cannabis use (RCU) among people living HIV (PLWH). Over a 14-day period, PLWH (N = 29) who engaged in both MCU and RCU completed a smartphone-based survey before and after every cannabis use event assessing general motivation for cannabis use (MCU-only, RCU-only, or mixed MCU/RCU), cannabis use behavior, and several antecedents and outcomes of cannabis use. A total of 739 pre-cannabis surveys were completed; 590 (80%) of the prompted post-cannabis surveys were completed. Motives for cannabis use were reported as MCU-only on 24%, RCU-only on 30%, and mixed MCU/RCU on 46% of pre-cannabis surveys. Mixed effects models examined within-person differences across MCU-only, RCU-only, and mixed MCU/RCU events. Results showed that relative to RCU-only events, MCU-only events were more likely to involve symptom management and drug substitution motives, physical and sleep-related symptoms, solitary cannabis use, and use of cannabis oils and sprays; MCU-only events were less likely to involve relaxation, happiness, and wellness motives, cannabis flower use, and positive cannabis consequences. Differences between mixed MCU/RCU and RCU-only events were similar, except that mixed MCU/RCU events were additionally associated with stress reduction motives and symptoms of anxiety and depression. Findings support the feasibility of partially disentangling MCU and RCU behavior among PLWH who engage in concurrent MCU and RCU. This study highlights the need for more EMA studies isolating MCU from RCU to inform ongoing changes to cannabis policies.
- 7 November 2022
- Published by Springer Nature in AIDS and Behavior
- Vol. 27 (4) , 1350-1363
Disentangling Medicinal and Recreational cannabis Use Among People Living with HIV: An Ecological Momentary Assessment Study
This study examined the feasibility of using ecological momentary assessment (EMA) to disentangle medicinal cannabis use (MCU) from recreational cannabis use (RCU) among people living HIV (PLWH). Over a 14-day period, PLWH (N = 29) who engaged in both MCU and RCU completed a smartphone-based survey before and after every cannabis use event assessing general motivation for cannabis use (MCU-only, RCU-only, or mixed MCU/RCU), cannabis use behavior, and several antecedents and outcomes of cannabis use. A total of 739 pre-cannabis surveys were completed; 590 (80%) of the prompted post-cannabis surveys were completed. Motives for cannabis use were reported as MCU-only on 24%, RCU-only on 30%, and mixed MCU/RCU on 46% of pre-cannabis surveys. Mixed effects models examined within-person differences across MCU-only, RCU-only, and mixed MCU/RCU events. Results showed that relative to RCU-only events, MCU-only events were more likely to involve symptom management and drug substitution motives, physical and sleep-related symptoms, solitary cannabis use, and use of cannabis oils and sprays; MCU-only events were less likely to involve relaxation, happiness, and wellness motives, cannabis flower use, and positive cannabis consequences. Differences between mixed MCU/RCU and RCU-only events were similar, except that mixed MCU/RCU events were additionally associated with stress reduction motives and symptoms of anxiety and depression. Findings support the feasibility of partially disentangling MCU and RCU behavior among PLWH who engage in concurrent MCU and RCU. This study highlights the need for more EMA studies isolating MCU from RCU to inform ongoing changes to cannabis policies.
- 16 September 2022
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 160 (3) , 751-761
The social and economic impacts of cervical cancer on women and children in low‐ and middle‐income countries: A systematic review
Background: There is limited knowledge on the social and economic impacts of a diagnosis of cervical cancer on women and children in low‐ and middle‐income countries (LMICs).Objectives: To determine the social and economic impacts associated with cervical cancer among women and children living in LMICs.Search strategy: The MEDLINE, PsychInfo, CINAHL, Pais International, and CAB Global Health databases were systematically searched to retrieve studies up to June 2021.Selection criteria: Studies were included if they reported on either the social or economic impacts of women or children in a LMIC.Data collection and analysis: Data was independently extracted by two co‐authors. The authors performed a quality assessment on all included articles.Main results: In all, 53 studies were included in the final review. Social impacts identified included social support, education, and independence. Economic impacts included employment and financial security. No study reported the economic impact on children. Studies that utilized quantitative methods typically reported more positive results than those that utilized qualitative methods.Conclusions: Additional mixed‐methods research is needed to further understand the social support needs of women with cervical cancer. Furthermore, research is needed on the impact of a mother's diagnosis of cervical cancer on her children.
- 16 September 2022
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 160 (3) , 751-761
The social and economic impacts of cervical cancer on women and children in low‐ and middle‐income countries: A systematic review
Background: There is limited knowledge on the social and economic impacts of a diagnosis of cervical cancer on women and children in low‐ and middle‐income countries (LMICs).Objectives: To determine the social and economic impacts associated with cervical cancer among women and children living in LMICs.Search strategy: The MEDLINE, PsychInfo, CINAHL, Pais International, and CAB Global Health databases were systematically searched to retrieve studies up to June 2021.Selection criteria: Studies were included if they reported on either the social or economic impacts of women or children in a LMIC.Data collection and analysis: Data was independently extracted by two co‐authors. The authors performed a quality assessment on all included articles.Main results: In all, 53 studies were included in the final review. Social impacts identified included social support, education, and independence. Economic impacts included employment and financial security. No study reported the economic impact on children. Studies that utilized quantitative methods typically reported more positive results than those that utilized qualitative methods.Conclusions: Additional mixed‐methods research is needed to further understand the social support needs of women with cervical cancer. Furthermore, research is needed on the impact of a mother's diagnosis of cervical cancer on her children.
- Open Access
- 14 June 2022
- Published by Wiley in HIV Medicine
- Vol. 24 (2) , 130-138
Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study
Background: While treatment guidelines for HIV in adults have evolved rapidly with the advent of new antiretroviral (ARV) treatment, those for the prevention of vertical HIV transmission in pregnancy have evolved more slowly due to safety and efficacy concerns. Here we describe Canadian prescribing patterns for ARV treatments during pregnancy and compare them to perinatal HIV prescribing guidelines of the United States Department of Health and Human Services (HHS), that are commonly used in Canada and include recommendations for newly commercialized therapies.Methods: The Canadian Perinatal HIV Surveillance Program (CPHSP) captures annual medical data on mothers living with HIV and their infants from 23 sites across Canada. Women from this cohort who received an ARV treatment during pregnancy and who gave birth between 2004 and 2020 were included in the study. ARV treatments were designated as ‘preferred/alternative’ as per HHS HIV perinatal guidelines, or ‘other than preferred/alternative’.Results: We identified 3673 pregnancies from 2720 women. The proportion of women that conceived while on ARV treatment increased from 29% in 2003 to 90% in 2020. Other than preferred/alternative ARV treatments were received in 1112 (30%) of pregnancies and this was significantly associated with having initiated ARV treatment before conception.Conclusion: In Canada during the study period, a high number of women were prescribed an other than preferred/alternative ARV treatment during pregnancy. Further optimization of ARV treatment in women of childbearing age living with HIV is warranted.
- 14 June 2022
- Published by Wiley in HIV Medicine
- Vol. 24 (2) , 130-138
Open AccessPrescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study
Background: While treatment guidelines for HIV in adults have evolved rapidly with the advent of new antiretroviral (ARV) treatment, those for the prevention of vertical HIV transmission in pregnancy have evolved more slowly due to safety and efficacy concerns. Here we describe Canadian prescribing patterns for ARV treatments during pregnancy and compare them to perinatal HIV prescribing guidelines of the United States Department of Health and Human Services (HHS), that are commonly used in Canada and include recommendations for newly commercialized therapies.Methods: The Canadian Perinatal HIV Surveillance Program (CPHSP) captures annual medical data on mothers living with HIV and their infants from 23 sites across Canada. Women from this cohort who received an ARV treatment during pregnancy and who gave birth between 2004 and 2020 were included in the study. ARV treatments were designated as ‘preferred/alternative’ as per HHS HIV perinatal guidelines, or ‘other than preferred/alternative’.Results: We identified 3673 pregnancies from 2720 women. The proportion of women that conceived while on ARV treatment increased from 29% in 2003 to 90% in 2020. Other than preferred/alternative ARV treatments were received in 1112 (30%) of pregnancies and this was significantly associated with having initiated ARV treatment before conception.Conclusion: In Canada during the study period, a high number of women were prescribed an other than preferred/alternative ARV treatment during pregnancy. Further optimization of ARV treatment in women of childbearing age living with HIV is warranted.
- Open Access
- 14 March 2022
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 10 (3) , e33940
Use of an mHealth Ketogenic Diet App Intervention and User Behaviors Associated With Weight Loss in Adults With Overweight or Obesity: Secondary Analysis of a Randomized Clinical Trial
Background: Low-carbohydrate ketogenic diets are a viable method to lose weight that have regained popularity in recent years. Technology in the form of mobile health (mHealth) apps allows for scalable and remote delivery of such dietary interventions and are increasingly being used by the general population without direct medical supervision. However, it is currently unknown which factors related to app use and user behavior are associated with successful weight loss. Objective: First, to describe and characterize user behavior, we aim to examine characteristics and user behaviors over time of participants who were enrolled in a remotely delivered clinical weight loss trial that tested an mHealth ketogenic diet app paired with a breath acetone biofeedback device. Second, to identify variables of importance to weight loss at 12 weeks that may offer insight for future development of dietary mHealth interventions, we aim to explore which app- and adherence-related user behaviors characterized successful weight loss. Methods: We analyzed app use and self-reported questionnaire data from 75 adults with overweight or obesity who participated in the intervention arm of a previous weight loss study. We examined data patterns over time through linear mixed models and performed correlation, linear regression, and causal mediation analyses to characterize diet-, weight-, and app-related user behavior associated with weight loss. Results: In the context of a low-carbohydrate ketogenic diet intervention delivered remotely through an mHealth app paired with a breath acetone biofeedback device, self-reported dietary adherence seemed to be the most important factor to predict weight loss (β=–.31; t54=–2.366; P=.02). Furthermore, self-reported adherence mediated the relationship between greater app engagement (from c=–0.008, 95% CI –0.014 to –0.0019 to c’=–0.0035, 95% CI –0.0094 to 0.0024) or higher breath acetone levels (from c=–1.34, 95% CI –2.28 to –0.40 to c’=–0.40, 95% CI –1.42 to 0.62) and greater weight loss, explaining a total of 27.8% and 28.8% of the variance in weight loss, respectively. User behavior (compliance with weight measurements and app engagement) and adherence-related aspects (breath acetone values and self-reported dietary adherence) over time differed between individuals who achieved a clinically significant weight loss of >5% and those who did not. Conclusions: Our in-depth examination of app- and adherence-related user behaviors offers insight into factors associated with successful weight loss in the context of mHealth interventions. In particular, our finding that self-reported dietary adherence was the most important metric predicting weight loss may aid in the development of future mHealth dietary interventions. Trial Registration: ClinicalTrials.gov NCT04165707; https://clinicaltrials.gov/ct2/show/NCT04165707 International Registered Report Identifier (IRRID): RR2-10.2196/19053
- 14 March 2022
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 10 (3) , e33940
Open AccessUse of an mHealth Ketogenic Diet App Intervention and User Behaviors Associated With Weight Loss in Adults With Overweight or Obesity: Secondary Analysis of a Randomized Clinical Trial
Background: Low-carbohydrate ketogenic diets are a viable method to lose weight that have regained popularity in recent years. Technology in the form of mobile health (mHealth) apps allows for scalable and remote delivery of such dietary interventions and are increasingly being used by the general population without direct medical supervision. However, it is currently unknown which factors related to app use and user behavior are associated with successful weight loss. Objective: First, to describe and characterize user behavior, we aim to examine characteristics and user behaviors over time of participants who were enrolled in a remotely delivered clinical weight loss trial that tested an mHealth ketogenic diet app paired with a breath acetone biofeedback device. Second, to identify variables of importance to weight loss at 12 weeks that may offer insight for future development of dietary mHealth interventions, we aim to explore which app- and adherence-related user behaviors characterized successful weight loss. Methods: We analyzed app use and self-reported questionnaire data from 75 adults with overweight or obesity who participated in the intervention arm of a previous weight loss study. We examined data patterns over time through linear mixed models and performed correlation, linear regression, and causal mediation analyses to characterize diet-, weight-, and app-related user behavior associated with weight loss. Results: In the context of a low-carbohydrate ketogenic diet intervention delivered remotely through an mHealth app paired with a breath acetone biofeedback device, self-reported dietary adherence seemed to be the most important factor to predict weight loss (β=–.31; t54=–2.366; P=.02). Furthermore, self-reported adherence mediated the relationship between greater app engagement (from c=–0.008, 95% CI –0.014 to –0.0019 to c’=–0.0035, 95% CI –0.0094 to 0.0024) or higher breath acetone levels (from c=–1.34, 95% CI –2.28 to –0.40 to c’=–0.40, 95% CI –1.42 to 0.62) and greater weight loss, explaining a total of 27.8% and 28.8% of the variance in weight loss, respectively. User behavior (compliance with weight measurements and app engagement) and adherence-related aspects (breath acetone values and self-reported dietary adherence) over time differed between individuals who achieved a clinically significant weight loss of >5% and those who did not. Conclusions: Our in-depth examination of app- and adherence-related user behaviors offers insight into factors associated with successful weight loss in the context of mHealth interventions. In particular, our finding that self-reported dietary adherence was the most important metric predicting weight loss may aid in the development of future mHealth dietary interventions. Trial Registration: ClinicalTrials.gov NCT04165707; https://clinicaltrials.gov/ct2/show/NCT04165707 International Registered Report Identifier (IRRID): RR2-10.2196/19053
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Community-Integrated Self-Collection HPV-Based Cervix Screening Programs to Increase Screening and Treatment Coverage: Results from a Pragmatic, Cluster-Randomized Trial
Background: The WHO’s cervical cancer elimination strategy calls for 70% screened and 90% with cervical disease treated. Human papillomavirus (HPV) testing increases access to cervix screening, improving screening and treatment uptake. Self-collection screening is acceptable and feasible. However, data are needed to inform policy on how health systems can best integrate self-collection HPV-based screening programs within existing infrastructure to optimize screening and treatment coverage. Methods: ASPIRE Mayuge was a pragmatic cluster-randomized trial in Uganda comparing implementation strategies for self-collection screening: door-to-door and community health days. Villages were randomized to strategy. Participants ages 25-29 with no prior cervix treatment were eligible. Participants completed a survey and self-collection screening. The primary outcome was follow-up attendance at local health centers after a positive screen. We ran mixed-effects logistic regression models to compare outcomes between arms. Findings: A total of 31 villages and 2,019 participants were randomized (Arm 1: 16 clusters, 1055 participants; Arm 2: 15 clusters, 964 participants). Among HPV positive participants, follow-up attendance rates were 75% (Arm 1) and 66% (Arm 2). The adjusted regression model showed Arm 2 had lower odds of follow-up attending (OR = 0·67, 95% CI: 0·38-1·19). Interpretation: Both models were feasibly integrated into existing infrastructure and led to high rates of follow-up attendance. The door-to-door model, with individualized education, may encourage better follow-up attendance; however, community health days required fewer personnel and allowed for bundling of services. Jurisdictions can use this trial as a roadmap for implementation and determine which approach is best suited for their setting. Trial Registration Details: ISRCTN, ISRCTN12767014. Registered 14 May 2019, https://doi.org/10.1186/ISRCTN12767014; clinicaltrials.gov, NCT04000503; Registered 27 June 2019, https://clinicaltrials.gov/ct2/show/NCT04000503. Funding Information: This work was supported by a Canadian Health Research Institutes Foundation grant awarded to Professor Gina Ogilvie (CIHR FDN-143339). Declaration of Interests: No conflicts of interest exist. Ethics Approval Statement: Ethics approval was obtained from the University of British Columbia / Children’s and Women’s Health Centre of British Columbia Research Ethics Board (UBC C&W REB # H17–0333) and the Uganda Cancer Institute (UCIREC REF-02-2018). All study participants provided informed consent.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessCommunity-Integrated Self-Collection HPV-Based Cervix Screening Programs to Increase Screening and Treatment Coverage: Results from a Pragmatic, Cluster-Randomized Trial
Background: The WHO’s cervical cancer elimination strategy calls for 70% screened and 90% with cervical disease treated. Human papillomavirus (HPV) testing increases access to cervix screening, improving screening and treatment uptake. Self-collection screening is acceptable and feasible. However, data are needed to inform policy on how health systems can best integrate self-collection HPV-based screening programs within existing infrastructure to optimize screening and treatment coverage. Methods: ASPIRE Mayuge was a pragmatic cluster-randomized trial in Uganda comparing implementation strategies for self-collection screening: door-to-door and community health days. Villages were randomized to strategy. Participants ages 25-29 with no prior cervix treatment were eligible. Participants completed a survey and self-collection screening. The primary outcome was follow-up attendance at local health centers after a positive screen. We ran mixed-effects logistic regression models to compare outcomes between arms. Findings: A total of 31 villages and 2,019 participants were randomized (Arm 1: 16 clusters, 1055 participants; Arm 2: 15 clusters, 964 participants). Among HPV positive participants, follow-up attendance rates were 75% (Arm 1) and 66% (Arm 2). The adjusted regression model showed Arm 2 had lower odds of follow-up attending (OR = 0·67, 95% CI: 0·38-1·19). Interpretation: Both models were feasibly integrated into existing infrastructure and led to high rates of follow-up attendance. The door-to-door model, with individualized education, may encourage better follow-up attendance; however, community health days required fewer personnel and allowed for bundling of services. Jurisdictions can use this trial as a roadmap for implementation and determine which approach is best suited for their setting. Trial Registration Details: ISRCTN, ISRCTN12767014. Registered 14 May 2019, https://doi.org/10.1186/ISRCTN12767014; clinicaltrials.gov, NCT04000503; Registered 27 June 2019, https://clinicaltrials.gov/ct2/show/NCT04000503. Funding Information: This work was supported by a Canadian Health Research Institutes Foundation grant awarded to Professor Gina Ogilvie (CIHR FDN-143339). Declaration of Interests: No conflicts of interest exist. Ethics Approval Statement: Ethics approval was obtained from the University of British Columbia / Children’s and Women’s Health Centre of British Columbia Research Ethics Board (UBC C&W REB # H17–0333) and the Uganda Cancer Institute (UCIREC REF-02-2018). All study participants provided informed consent.